Results 241 to 250 of about 609,595 (394)
UK Cervical Cancer Screening Programme: Setting a Research Agenda
Christina Davies, Jackie Brown
openalex +1 more source
Schematic model of CJP–TiN liposomes for gastric cancer (GC) treatment. Internalizing RGD peptide (iRGD) targets tumor cells, while Chlorin e6 (Ce6) generates reactive oxygen species (ROS). Jolkinolide B (JB) activates the PANoptosis pathway via caspase‐8, enhancing GC cell death and immune response, transforming “cold tumors” into “hot tumors” by ...
Chenhui Ma+14 more
wiley +1 more source
Evaluating the Cost-Effectiveness of Cervical Cancer Screening and Treatment in Western Romania. [PDF]
Petre I+10 more
europepmc +1 more source
Analysis of Cervical Cancer Mortality and Incidence Data from England and Wales: Evidence of a Beneficial Effect of Screening [PDF]
Peter Sasieni, Joanna Adams
openalex +1 more source
Cisplatin causes reactive oxygen species accumulation, leading to apoptosis and inflammation in cochlear hair cells. Small extracellular vesicles primarily derived from the damaged hair cells likely contribute to cisplatin‐induced ototoxicity, carrying a variety of microRNAs and proteins.
Jingru Ai+14 more
wiley +1 more source
The clinical performance of different cervical cancer screening strategies in premenopausal and postmenopausal women. [PDF]
Zhou Q+11 more
europepmc +1 more source
HPV-based cervical cancer screening in a population at high risk for HIV infection [PDF]
Sharita D. Womack+8 more
openalex +1 more source
KRAS mutations dynamically remodel the tumor microenvironment (TME), fostering immunosuppression, metabolic symbiosis, and stromal plasticity. This review dissects how oncogenic KRAS variants sculpt TME networks and explores actionable vulnerabilities. Emerging strategies combining KRAS inhibitors and TME‐editing approaches offer potential to dismantle
Jiayao Ma+9 more
wiley +1 more source
Progress in the application research of cervical cancer screening developed by artificial intelligence in large populations. [PDF]
Liao W, Xu X.
europepmc +1 more source